Ethnic differences in expression of susceptibility marker(s) in rheumatic fever/rheumatic heart disease patients

International Journal of Cardiology

Volumn 64, Issue 1, 1998, Pages 9-14

  Kaur, S ^a   Kumar, D ^a   Grover, A ^a   Khanduja, K L ^a   Kaplan, E L ^b   Gray, E D ^b   Ganguly, N K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Genetic influence; Group A streptococci; Monoclonal antibodies; Rheumatic fever; Rheumatic heart disease

Indexed keywords

ALLOANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LYMPHOCYTE ANTIGEN; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; FEMALE; FLOW CYTOMETRY; GENETIC SUSCEPTIBILITY; HUMAN; MALE; PRIORITY JOURNAL; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; CHILD; CHILD, PRESCHOOL; CLONE CELLS; DISEASE SUSCEPTIBILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENETIC MARKERS; GENETIC SCREENING; HUMANS; INDIA; MALE; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SENSITIVITY AND SPECIFICITY;

EID: 0032513185     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(98)00009-6     Document Type: Article

References (21)

1. Padmavati S. Rheumatic fever and rheumatic heart disease in developing countries. Bull WHO. 56:1978;543-550.
2. Zaheer M., Sinha S.N., Tiwari S.G., Rasheed P., Khan A., Zaidi S.A. Rheumatic heart disease. A survey among school-going children at Aligarh. Indian Heart Journal. 25:1973;289-293.
3. Mathur K.S., Banerji S.C., Nigam D.K., Prasad R. Rheumatic heart disease and rheumatic fever-prevalence in a village community of Bichpuri Block Agra. J Assoc Physicians India. 19:1971;151-156.
4. Vijaykumar M., Narula J., Reddy K.S., Kaplan E.L. Incidence of rheumatic fever and prevalence of rheumatic heart disease in India. Int J Cardiol. 43:1994;221-228.
5. Kaplan E.L. T. Duckett Jones Memorial Lecture. Global assessment of rheumatic fever and rheumatic heart disease at the close of the century. Influences and dynamics of populations and pathogens: a failure to realize prevention? Circulation. 88:1993;1964-1972.
6. Grover A., Dhawan A., Iyengar S.D., Anand I.S., Wahi P.L., Ganguly N.K. Epidemiology of rheumatic fever and rheumatic heart disease in a rural community in northern India. Bull WHO. 71:1993;59-66.
7. WHO. Rheumatic fever and rheumatic heart disease - report of a WHO study group. WHO Tech Rep Ser 1988;764:1-58.
8. Cheadle W.B. Harvey lectures on the various manistations of the rheumatic state as exemplified in childhood and early life. Lancet. 1:1889;821-832.
9. Taranta A., Torosdag S., Metrakos J.D., Jefier W., Uchida I. Rheumatic fever in monzygotic and dizygotic twins. Circulation. 20:1959;778.
10. Wilson M.G., Schweitzer M.D., Lubschez R. The familial epidemiology of rheuatic fever: Genetic and epidemiologic studies. J Pediatr. 22:1943;468-492. Also pp. 581-611.
11. Patarroyo M.E., Winchester R.J., Vejerano A.et al. Association of a B-cell alloantigen with susceptibility to rheumatic fever. Nature. 278:1979;173-174.
12. Khanna A.K., Buskirk D.R., Williams R.C. Jr.et al. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest. 83:1989;1710-1716.
13. Zabriskie J.B., Lavenchy D., Williams R.C. Jr.et al. Rheumatic fever-associated B cell alloantigens as identified by monoclonal antibodies. Arthritis Rheum. 28:1985;1047-1051.
14. Taneja V., Mehra N.K., Reddy K.S.et al. HLA-DR/DQ antigens and reactivity to B cell alloantigen D8/17 in Indian patients with rheumatic heart disease. Circulation. 80:1989;335-340.
15. Ganguly N.K., Anand I.S., Koicha M., Jindal S., Wahi P.L. Frequency of D8/17 B lymphocyte alloantigen in north Indian patients with rheumatic heart disease. Immunol Cell Biol. 70:1992;9-14.
16. Special writing group of the committee on rheumatic fever, endocarditis, and Kawasaki disease of the council on cardiovascular disease in the young of the American Heart Association. Guidelines for the diagnosis of rheumatic fever - Jones criteria, 1992 update. JAMA 1992;268:2069-73.
17. Julius M.H., Simpson E., Herzenberg L.A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 3:1973;645-649.
18. Morris R.E. Cellular enzyme-linked immunospecific assay (CELISA). III. Use of the CELISA to quantitate monoclonal antibodies bound to HLA antigens and to subset-specific antigens on cell surfaces. Transplantation. 36:1983;719-725.
19. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256:1975;495-497.
20. Erber W.N., Pinching A.J., Mason D.Y. Immunocytochemical detection of T and B cell populations in routine blood smears. Lancet. 1:1984;1042-1046.
21. Gray E.D., Regelmann W.E., Abdin Z.et al. Compartmentalization of cells bearing "rheumatic" cell surface antigens in peripheral blood and tonsils in rheumatic heart disease. J Infect Dis. 155:1987;247-252.